Filing Details
- Accession Number:
- 0001299130-21-000070
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-18 21:52:14
- Reporting Period:
- 2021-02-16
- Accepted Time:
- 2021-02-18 21:52:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1299130 | Pacific Biosciences Of California Inc. | PACB | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1222643 | Kathy Ordonez | Pacific Biosciences Of California, Inc. 1305 O'Brien Drive Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-02-16 | 35,000 | $6.98 | 91,767 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-02-16 | 25,000 | $5.79 | 116,767 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-02-16 | 25,000 | $8.98 | 141,767 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-02-16 | 25,000 | $3.81 | 166,767 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-02-16 | 25,485 | $2.90 | 192,252 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-02-16 | 50,394 | $2.63 | 242,646 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-02-16 | 118,667 | $47.58 | 123,979 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-02-16 | 101,004 | $48.47 | 22,975 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-02-16 | 1,100 | $49.00 | 21,875 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2021-02-16 | 35,000 | $0.00 | 35,000 | $6.98 |
Common Stock | Stock Option (right to buy) | Disposition | 2021-02-16 | 25,000 | $0.00 | 25,000 | $5.79 |
Common Stock | Stock Option (right to buy) | Disposition | 2021-02-16 | 25,000 | $0.00 | 25,000 | $8.98 |
Common Stock | Stock Option (right to buy) | Disposition | 2021-02-16 | 25,000 | $0.00 | 25,000 | $3.81 |
Common Stock | Stock Option (right to buy) | Disposition | 2021-02-16 | 25,485 | $0.00 | 25,485 | $2.90 |
Common Stock | Stock Option (right to buy) | Disposition | 2021-02-16 | 50,394 | $0.00 | 50,394 | $2.63 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2024-12-17 | No | 4 | M | Direct | |
0 | 2025-05-20 | No | 4 | M | Direct | |
0 | 2026-05-17 | No | 4 | M | Direct | |
0 | 2027-05-24 | No | 4 | M | Direct | |
324,515 | 2017-12-15 | 2027-11-15 | No | 4 | M | Direct |
37,106 | 2018-03-15 | 2028-03-15 | No | 4 | M | Direct |
Footnotes
- This sale price represents the weighted average sale price of the shares sold ranging from $47.00 to $47.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4
- This sale price represents the weighted average sale price of the shares sold ranging from $48.00 to $48.98 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4
- The shares subject to the option are fully vested and exercisable
- The shares subject to the option vest in equal monthly installment, over a four year period